Genome-wide association for methamphetamine dependence: convergent results from 2 samples.
paper
Cited
Public
Unavailable
- Authors
- Uhl, George R; Drgon, Tomas; Liu, Qing-Rong; Johnson, Catherine; Walther, Donna; Komiyama, Tokutaro; Harano, Mutsuo; Sekine, Yoshimoto; Inada, Toshiya; Ozaki, Norio; Iyo, Masaomi; Iwata, Nakao; Yamada, Mitsuhiko; Sora, Ichiro; Chen, Chih-Ken; Liu, Hsing-Cheng; Ujike, Hiroshi; Lin, Shih-Ku
- Year
- 2008
- Journal
- Archives of general psychiatry
- PMID
- 18316681
- DOI
- 10.1001/archpsyc.65.3.345
CONTEXT: We can improve understanding of human methamphetamine dependence, and possibly our abilities to prevent and treat this devastating disorder, by identifying genes whose allelic variants predispose to methamphetamine dependence. OBJECTIVE: To find "methamphetamine dependence" genes identified by each of 2 genome-wide association (GWA) studies of independent samples of methamphetamine-dependent individuals and matched controls. DESIGN: Replicated GWA results in each of 2 case-control studies. SETTING: Japan and Taiwan. PARTICIPANTS: Individuals with methamphetamine dependence and matched control subjects free from psychiatric, substance abuse, or substance dependence diagnoses (N = 580). MAIN OUTCOME MEASURES: "Methamphetamine dependence" genes that were reproducibly identified by clusters of nominally positive single-nucleotide polymorphisms (SNPs) in both samples in ways that were unlikely to represent chance observations, based on Monte Carlo simulations that corrected for multiple comparisons, and subsets of "methamphetamine dependence" genes that were also identified by GWA studies of dependence on other addictive substances, success in quitting smoking, and memory. RESULTS: Genes identified by clustered nominally positive SNPs from both samples were unlikely to represent chance observations (Monte Carlo P < .00001). Variants in these "methamphetamine dependence" genes are likely to alter cell adhesion, enzymatic functions, transcription, cell structure, and DNA, RNA, and/or protein handling or modification. Cell adhesion genes CSMD1 and CDH13 displayed the largest numbers of clustered nominally positive SNPs. "Methamphetamine dependence" genes overlapped, to extents much greater than chance, with genes identified in GWA studies of dependence on other addictive substances, success in quitting smoking, and memory (Monte Carlo P range < .04 to < .00001). CONCLUSION: These data support polygenic contributions to methamphetamine dependence from genes that include those whose variants contribute to dependence on several addictive substances, success in quitting smoking, and mnemonic processes.
No figures extracted from this document.
No chunks — full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
No citations found.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Neurostructural alterations, trait impulsivity, and genetic architecture in individuals with methamphetamine dependence: a multimodal imaging-genetics study. | Luo D et al. | — | 2026 | → |
| A genome-wide association study of methamphetamine use among people with HIV. | Venkataraman A et al. | — | 2025 | → |
| Genes, Cognition, and Their Interplay in Methamphetamine Use Disorder. | Khan R et al. | — | 2025 | → |
| Associations between methamphetamine use disorder and <i>SLC18A1</i>, <i>SLC18A2</i>, <i>BDNF</i>, and <i>FAAH</i> gene sequence variants and expression levels. | Guerin AA et al. | — | 2024 | → |
| Selecting the appropriate hurdles and endpoints for pentilludin, a novel antiaddiction pharmacotherapeutic targeting the receptor type protein tyrosine phosphatase D. | Uhl GR | — | 2023 | → |
| Genetic variants associated with acamprosate treatment response in alcohol use disorder patients: A multiple omics study. | Ho MF et al. | — | 2022 | → |
| A Common <i>CDH13</i> Variant Is Associated with Low Agreeableness and Neural Responses to Working Memory Tasks in ADHD. | Ziegler GC et al. | — | 2021 | → |
| Genetic basis of variation in cocaine and methamphetamine consumption in outbred populations of <i>Drosophila melanogaster</i>. | Baker BM et al. | — | 2021 | → |
| Genetic Basis of Variation in Cocaine and Methamphetamine Consumption in Outbred Populations of<i>Drosophila melanogaster</i> | Baker BM et al. | — | 2021 | — |
| Genetics of methamphetamine use disorder: A systematic review and meta-analyses of gene association studies. | Guerin AA et al. | — | 2021 | → |
| Genome-wide association study of stimulant dependence. | Cox J et al. | — | 2021 | → |
| Intracranial self-stimulation and concomitant behaviors following systemic methamphetamine administration in Hnrnph1 mutant mice. | Borrelli KN et al. | — | 2021 | → |
| Serotonin-specific neurons differentiated from human iPSCs form distinct subtypes with synaptic protein assembly. | Jansch C et al. | — | 2021 | → |
| No Association Between AKT1 Polymorphisms and Methamphetamine Addiction in Iranian Population. | Ghafouri-Fard S et al. | — | 2020 | → |
| The Streetlight Effect: Reappraising the Study of Addiction in Light of the Findings of Genome-wide Association Studies. | Hall FS et al. | — | 2020 | → |
| Characterization of DSM-IV Opioid Dependence Among Individuals of European Ancestry. | Brick LA et al. | — | 2019 | → |
| Dissociation of impulsivity and aggression in mice deficient for the ADHD risk gene Adgrl3: Evidence for dopamine transporter dysregulation. | Mortimer N et al. | — | 2019 | → |
| Unravelling the genetic basis of schizophrenia and bipolar disorder with GWAS: A systematic review. | Prata DP et al. | — | 2019 | → |
| Cocaine reward is reduced by decreased expression of receptor-type protein tyrosine phosphatase D (PTPRD) and by a novel PTPRD antagonist. | Uhl GR et al. | — | 2018 | → |
| Human Genetics of Addiction: New Insights and Future Directions. | Hancock DB et al. | — | 2018 | → |
| Neuroepigenetics and addiction. | Walker DM et al. | — | 2018 | → |
| The Role of Cell Adhesion Molecule Genes Regulating Neuroplasticity in Addiction. | Muskiewicz DE et al. | — | 2018 | → |
| Alpha-1 antitrypsin inhibits RANKL-induced osteoclast formation and functions. | Akbar MA et al. | — | 2017 | → |
| Cadherin-13 Deficiency Increases Dorsal Raphe 5-HT Neuron Density and Prefrontal Cortex Innervation in the Mouse Brain. | Forero A et al. | — | 2017 | → |
| Pharmacogenetics of stimulant abuse liability: association of CDH13 variant with amphetamine response in a racially-heterogeneous sample of healthy young adults. | Leventhal AM et al. | — | 2017 | → |
| A Mouse Model for Binge-Level Methamphetamine Use. | Shabani S et al. | — | 2016 | → |
| A Review of Genome-Wide Association Studies of Stimulant and Opioid Use Disorders. | Jensen KP | — | 2016 | → |
| Behavioral and transcriptomic profiling of mice null for Lphn3, a gene implicated in ADHD and addiction. | Orsini CA et al. | — | 2016 | → |
| Cadherin 13: human <i>cis</i>-regulation and selectively-altered addiction phenotypes and cerebral cortical dopamine in knockout mice. | Drgonova J et al. | — | 2016 | → |
| Dopamine and serotonin genetic risk scores predicting substance and nicotine use in attention deficit/hyperactivity disorder. | Groenman AP et al. | — | 2016 | → |
| Genetic imaging consortium for addiction medicine: From neuroimaging to genes. | Mackey S et al. | — | 2016 | → |
| KAT2B polymorphism identified for drug abuse in African Americans with regulatory links to drug abuse pathways in human prefrontal cortex. | Johnson EO et al. | — | 2016 | → |
| Psychiatric genetics in China: achievements and challenges. | Liu C et al. | — | 2016 | → |
| Single nucleotide polymorphism near CREB1, rs7591784, is associated with pretreatment methamphetamine use frequency and outcome of outpatient treatment for methamphetamine use disorder. | Heinzerling KG et al. | — | 2016 | → |
| Summaries of plenary, symposia, and oral sessions at the XXII World Congress of Psychiatric Genetics, Copenhagen, Denmark, 12-16 October 2014. | Aas M et al. | — | 2016 | → |
| Association analysis of the Cadherin13 gene with schizophrenia in the Japanese population. | Otsuka I et al. | — | 2015 | → |
| Cadherin-13, a risk gene for ADHD and comorbid disorders, impacts GABAergic function in hippocampus and cognition. | Rivero O et al. | — | 2015 | → |
| Genome-Wide Association Study of Behavioral Disinhibition in a Selected Adolescent Sample. | Derringer J et al. | — | 2015 | → |
| Human cell adhesion molecules: annotated functional subtypes and overrepresentation of addiction-associated genes. | Zhong X et al. | — | 2015 | → |
| Multivariate analysis of subjective responses to d-amphetamine in healthy volunteers finds novel genetic pathway associations. | Yarosh HL et al. | — | 2015 | → |
| Persistent variations in neuronal DNA methylation following cocaine self-administration and protracted abstinence in mice. | Baker-Andresen D et al. | — | 2015 | → |
| The mammalian molybdenum enzymes of mARC. | Ott G et al. | — | 2015 | → |
| Curious cases: Altered dose-response relationships in addiction genetics. | Uhl GR et al. | — | 2014 | → |
| Mesocorticolimbic monoamine correlates of methamphetamine sensitization and motivation. | Lominac KD et al. | — | 2014 | → |
| Dances with black widow spiders: dysregulation of glutamate signalling enters centre stage in ADHD. | Lesch KP et al. | — | 2013 | → |
| Evidence for shared genetic risk between methamphetamine-induced psychosis and schizophrenia. | Ikeda M et al. | — | 2013 | → |
| Functional properties of rare missense variants of human CDH13 found in adult attention deficit/hyperactivity disorder (ADHD) patients. | Mavroconstanti T et al. | — | 2013 | → |
| Genetic factors involved in risk for methamphetamine intake and sensitization. | Belknap JK et al. | — | 2013 | → |
| Genetic variation of GRIN1 confers vulnerability to methamphetamine-dependent psychosis in a Thai population. | Chanasong R et al. | — | 2013 | → |
| Impact of the ADHD-susceptibility gene CDH13 on development and function of brain networks. | Rivero O et al. | — | 2013 | → |
| Implications of genome wide association studies for addiction: are our a priori assumptions all wrong? | Hall FS et al. | — | 2013 | → |
| Pharmacotherapy of amphetamine-type stimulant dependence: an update. | Brensilver M et al. | — | 2013 | → |
| The genetics of alcohol dependence. | Rietschel M et al. | — | 2013 | → |
| A common genetic network underlies substance use disorders and disruptive or externalizing disorders. | Arcos-Burgos M et al. | — | 2012 | → |
| Assessment of behaviors modeling aspects of schizophrenia in Csmd1 mutant mice. | Distler MG et al. | — | 2012 | → |
| Behavioural genetics of childhood disorders. | Freitag CM et al. | — | 2012 | → |
| Cadherins and neuropsychiatric disorders. | Redies C et al. | — | 2012 | → |
| Cadherins in brain morphogenesis and wiring. | Hirano S et al. | — | 2012 | → |
| Genetic factors modulating the response to stimulant drugs in humans. | Hart AB et al. | — | 2012 | → |
| Genome-wide association study of d-amphetamine response in healthy volunteers identifies putative associations, including cadherin 13 (CDH13). | Hart AB et al. | — | 2012 | → |
| Initial characterization of mice null for Lphn3, a gene implicated in ADHD and addiction. | Wallis D et al. | — | 2012 | → |
| MMPs and soluble ICAM-5 increase neuronal excitability within in vitro networks of hippocampal neurons. | Niedringhaus M et al. | — | 2012 | → |
| Mouse models for studying genetic influences on factors determining smoking cessation success in humans. | Hall FS et al. | — | 2012 | → |
| Quantitative and molecular genetics of ADHD. | Asherson P et al. | — | 2012 | → |
| ACSL6 is associated with the number of cigarettes smoked and its expression is altered by chronic nicotine exposure. | Chen J et al. | — | 2011 | → |
| CDH13 is associated with working memory performance in attention deficit/hyperactivity disorder. | Arias-Vásquez A et al. | — | 2011 | → |
| Genome-wide association studies of alcohol dependence and substance use disorders. | Treutlein J et al. | — | 2011 | → |
| Genomic regions identified by overlapping clusters of nominally-positive SNPs from genome-wide studies of alcohol and illegal substance dependence. | Johnson C et al. | — | 2011 | → |
| Meta-analysis and genome-wide interpretation of genetic susceptibility to drug addiction. | Li CY et al. | — | 2011 | → |
| Methamphetamine-associated cleavage of the synaptic adhesion molecule intercellular adhesion molecule-5. | Conant K et al. | — | 2011 | → |
| "Replicated" genome wide association for dependence on illegal substances: genomic regions identified by overlapping clusters of nominally positive SNPs. | Drgon T et al. | — | 2011 | → |
| The fourth mammalian molybdenum enzyme mARC: current state of research. | Havemeyer A et al. | — | 2011 | → |
| Case-control genome-wide association study of attention-deficit/hyperactivity disorder. | Neale BM et al. | — | 2010 | → |
| Do candidate genes discriminate patients with an autism spectrum disorder from those with attention deficit/hyperactivity disorder and is there an effect of lifetime substance use disorders? | Sizoo B et al. | — | 2010 | → |
| Genetics of drug dependence. | Gelernter J et al. | — | 2010 | → |
| Genome wide association for addiction: replicated results and comparisons of two analytic approaches. | Drgon T et al. | — | 2010 | → |
| Genome-wide association for smoking cessation success in a trial of precessation nicotine replacement. | Uhl GR et al. | — | 2010 | → |
| Genome-wide association for smoking cessation success: participants in the Patch in Practice trial of nicotine replacement. | Uhl GR et al. | — | 2010 | → |
| Genome-wide association scan of trait depression. | Terracciano A et al. | — | 2010 | → |
| Genome-wide association studies: a powerful tool for neurogenomics. | Cowperthwaite MC et al. | — | 2010 | → |
| Genome-wide association study identifies genes that may contribute to risk for developing heroin addiction. | Nielsen DA et al. | — | 2010 | → |
| High-throughput behavioral phenotyping in the expanded panel of BXD recombinant inbred strains. | Philip VM et al. | — | 2010 | → |
| Measuring addiction propensity and severity: the need for a new instrument. | Conway KP et al. | — | 2010 | → |
| Meta-analyses of genome-wide association studies identify multiple loci associated with pulmonary function. | Hancock DB et al. | — | 2010 | → |
| Molecular genetics of attention-deficit/hyperactivity disorder: an overview. | Banaschewski T et al. | — | 2010 | → |
| Parental consanguinity and susceptibility to drug abuse among offspring, a case-control study. | Saadat M et al. | — | 2010 | → |
| Pharmacogenetics of lithium response in bipolar disorder. | McCarthy MJ et al. | — | 2010 | → |
| Preliminary evidence of ethnic divergence in associations of putative genetic variants for methamphetamine dependence. | Bousman CA et al. | — | 2010 | → |
| Search for genetic markers and functional variants involved in the development of opiate and cocaine addiction and treatment. | Yuferov V et al. | — | 2010 | → |
| Transgenic mice in the study of drug addiction and the effects of psychostimulant drugs. | Sora I et al. | — | 2010 | → |
| Addiction genetics and pleiotropic effects of common haplotypes that make polygenic contributions to vulnerability to substance dependence. | Uhl GR et al. | — | 2009 | → |
| Convergent genome wide association results for bipolar disorder and substance dependence. | Johnson C et al. | — | 2009 | → |
| Genetically correlated effects of selective breeding for high and low methamphetamine consumption. | Wheeler JM et al. | — | 2009 | → |
| Genetic association studies of methamphetamine use disorders: A systematic review and synthesis. | Bousman CA et al. | — | 2009 | → |
| Genetics of attention-deficit hyperactivity disorder (ADHD). | Sharp SI et al. | — | 2009 | → |
| Genome-wide association for nicotine dependence and smoking cessation success in NIH research volunteers. | Drgon T et al. | — | 2009 | → |
| Genome-wide association for smoking cessation success: participants in a trial with adjunctive denicotinized cigarettes. | Drgon T et al. | — | 2009 | → |
| Genome-wide association studies in ADHD. | Franke B et al. | — | 2009 | → |
| Genome-wide association study of alcohol dependence. | Treutlein J et al. | — | 2009 | → |
| Glyceraldehyde-3-phosphate dehydrogenase aggregate formation participates in oxidative stress-induced cell death. | Nakajima H et al. | — | 2009 | → |
| Selected summaries from the XVI World Congress of Psychiatric Genetics, Osaka, Japan, 11-15 October 2008. | Bergen S et al. | — | 2009 | → |
| The genetics of attention-deficit/hyperactivity disorder. | Coghill D et al. | — | 2009 | → |
| Addiction Reviews. Preface. | Uhl GR | — | 2008 | → |
| Genome wide association for substance dependence: convergent results from epidemiologic and research volunteer samples. | Johnson C et al. | — | 2008 | → |
| Genome-wide association scan of quantitative traits for attention deficit hyperactivity disorder identifies novel associations and confirms candidate gene associations. | Lasky-Su J et al. | — | 2008 | → |
| Meta-analysis of genome-wide linkage scans of attention deficit hyperactivity disorder. | Zhou K et al. | — | 2008 | → |
| Molecular genetics of addiction and related heritable phenotypes: genome-wide association approaches identify "connectivity constellation" and drug target genes with pleiotropic effects. | Uhl GR et al. | — | 2008 | → |
| Molecular genetics of adult ADHD: converging evidence from genome-wide association and extended pedigree linkage studies. | Lesch KP et al. | — | 2008 | → |